The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s C-reactive protein testing market report forecasts the C-reactive protein testing market size to grow to $3.67 Billion by 2027, with a CAGR (compound annual growth rate) of more than 2%.

Learn More On The C-Reactive Protein Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cC-reactive-protein-testing-global-market-report

C-Reactive Protein Testing Market Size Forecast
The global C-reactive protein testing market is expected to grow from $3.28 billion in 2022 to $3.37 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The C-reactive protein testing market size is expected to grow to $3.67 billion in 2027 at a CAGR of 2.2%.

North America held the largest C-reactive protein testing market share, and Asia-Pacific was the fastest-growing region in 2022.

Key C-Reactive Protein Testing Market Driver ­– Increase In Cases Of Cardiovascular Diseases
For instance, according to the key facts published in June 2021 by the WHO (World Health Organization), cardiovascular diseases are the leading cause of death worldwide. Around 17.9 million die every year due to CVD, accounting for 32% of all global deaths. Therefore, the increasing cases of cardiovascular diseases will drive the C-reactive protein testing market.

Request for A Sample Of The Global C-Reactive Protein Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Key C-Reactive Protein Testing Market Trend – Technological Advancement In Measuring Devices
Major companies operating in the cC-reactive protein testing market are focused on providing technologically advanced solutions to strengthen their market position. These companies are implementing next-generation cC-reactive testing technologies into their testing methods and advanced solutions that provide benefits such as maximum output and multiple usages. For instance, in February 2022, Aidian, a Finnish-based diagnostic tests, and test solutions company, released the QuikRead go wrCRP & wrCRP+Hb kits. The kit consistently produces two results, a wide range of CRP and Hb, from a single sample with one analysis. The wide-range CRP test permits CRP readings to assess conditions such as neonatal sepsis, predict disease severity in COPD (chronic obstructive pulmonary disease), and assist in cardiovascular risk assessment.

C-Reactive Protein Testing Market Segment
1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
2) By End Use: Clinics, Hospitals, Diagnostic Laboratories
3) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

C-Reactive Protein Testing Market Major Players and Strategies
Major players in the C-reactive protein testing market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics, Siemens Healthineers, Abbott Laboratories, Laboratory Corporation of America Holdings, Merck, Abaxis Inc. (Zoetis), Ortho Clinical Diagnostics, Getein Biotech, Horiba, Randox Laboratories, Boditech Med, Eurolyser Diagnostica GmbH, Aidian, EKF Diagnostics, SD Biosensor Inc., Abcam plc, and Bio-Techne.

In October 2021, Abcam, a UK-based producer, distributor, and marketer of protein research tools, acquired BioVision Inc., for $340 million. This acquisition is expected to increase Abcam’s immunoassay capacity in Eugene, OR, by expanding the kits and assay portfolio. In addition to accelerating strategy execution, the company will also focus on in-house innovation and product development in the complementary biochemical and cell-based assay markets. BioVision Inc. is a US-based innovator and distributor of life science research tools, including CRP ELISA kits, to biopharma, diagnostic, and academic customers.

The C-Reactive Protein Testing Global Market Report 2023 covers regional data on C-reactive protein testing market size, C-reactive protein testing market trends and drivers, opportunities, strategies, and C-reactive protein testing market competitor analysis. The countries covered in the C-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

C-reactive protein testing measures the level of C-reactive protein (CRP) in the blood. CRP is a liver-produced protein released into the bloodstream due to inflammation. When the body is wounded or infected, inflammation is the body’s way of protecting the tissues. CRP testing is generally used to diagnose inflammation caused due to an infection.

View More Reports Related To The C-Reactive Protein Testing Market –
Protein Expression Global Market Report 2023
Protein Inhibitors Global Market Report 2023
Therapeutic Proteins Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: